Guidance on classification for reproductive toxicity under the globally harmonized system of classification and labelling of chemicals (GHS)

• Published in: Critical reviews in toxicology 2013-11, Vol.43 (10), p.850-891
• Main Authors: Moore, Nigel P., Boogaard, Peter J., Bremer, Susanne, Buesen, Roland, Edwards, James, Fraysse, Benoit, Hallmark, Nina, Hemming, Helena, Langrand-Lerche, Carole, McKee, Richard H., Meisters, Marie-Louise, Parsons, Paul, Politano, Valerie, Reader, Stuart, Ridgway, Peter, Hennes, Christa
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Butadienes - classification; Butadienes - toxicity; Classification; Ethanolamines - classification; Ethanolamines - toxicity; Female; General aspects. Methods; globally harmonised system of classification and labelling of chemicals (GHS); Guidelines as Topic; hazard; Hazardous Substances - classification; Hazardous Substances - toxicity; Internationality; Male; Medical sciences; mode of action; Nitrobenzenes - classification; Nitrobenzenes - toxicity; Phthalic Acids - classification; Phthalic Acids - toxicity; Product Labeling; Reproduction - drug effects; Toxicity Tests; toxicity to reproduction; Toxicology
• ISSN: 1040-8444; 1547-6898
• DOI: 10.3109/10408444.2013.854734

Abstract The Globally Harmonised System of Classification (GHS) is a framework within which the intrinsic hazards of substances may be determined and communicated. It is not a legislative instrument per se, but is enacted into national legislation with the appropriate legislative instruments. GHS covers many aspects of effects upon health and the environment, including adverse effects upon sexual function and fertility or on development. Classification for these effects is based upon observations in humans or from properly designed experiments in animals, although only the latter is covered herein. The decision to classify a substance based upon experimental data, and the category of classification ascribed, is determined by the level of evidence that is available for an adverse effect on sexual function and fertility or on development that does not arise as a secondary non-specific consequence of other toxic effect. This document offers guidance on the determination of level of concern as a measure of adversity, and the level of evidence to ascribe classification based on data from tests in laboratory animals.